How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

VI

OOTC:VIAP
Get a brief AI stock analysisSaves ~ 15 minutes of your time

VI

VIA Pharmaceuticals IncOOTC VIAP Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is VIAP undervalued compared to its fair value?

The fair value of VIAP stock is hidden USD. Relative to the market price of 0 USD VIA Pharmaceuticals Inc is hidden.

VIA Pharmaceuticals, Inc. (VIA) is a development-stage biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. The Company’s lead compound, VIA-2291, targe...[More about valuation]

VIA Pharmaceuticals Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

Price:

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

STOCK ANALYSIS

Is VIAP attractive for investment based on fundamental analysis?

VIAP stock rating is hidden. VIA Pharmaceuticals is a hidden by Eyestock methodology.

Get VIAP Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

VIAP analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for VIAP to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

VIA Pharmaceuticals Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

VIA Pharmaceuticals Inc dividends

VIAP dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About VIAP stock

About the company VIA Pharmaceuticals Inc

Market cap $B

Dividend yield

Shares outstanding

20.56 B

Website

VIA Pharmaceuticals, Inc. (VIA) is a development-stage biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. The Company’s lead compound, VIA-2291, targets an unmet medical need of reducing atherosclerotic plaque inflammation, which is an underlying cause of atherosclerosis and its complications. Atherosclerosis is a cardiovascular disease that results from chronic inflammation and the build-up of plaque in arterial blood vessel walls. The Company’s clinical development strategy integrates several technologies to provide clinical proof-of-concept, as early as possible in the clinical development process. These technologies include the measurement of biomarkers, medical imaging of the coronary and carotid vessel walls to evaluate the plaque characteristics, and atherosclerotic plaque bioassays.

VIAP profile

  • Ticker

    VIAP

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    18 April 2000

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    6

  • City

    San Francisco

  • Address

    750 Battery St Ste 330

  • Cusip

    92554T103